Comparison of post-treatment recurrence between ranibizumab injection and laser photocoagulation for type 1 retinopathy of prematurity

YIC-IR

	Comparison of post-treatment recurrence between ranibizumab injection and laser photocoagulation for type 1 retinopathy of prematurity
	Jing-Ke Cao 1; Tao Han 2; Hong-Yi Tang 3; Sheng Zhang 2; Zong-Hua Wang 4; Zhi-Chun Feng 2; Qiu-Ping Li 1
发表期刊	BMC OPHTHALMOLOGY
ISSN	1471-2415
	2023
卷号	23 期号:1 页码:1-8
英文摘要	To compare post-treatment recurrence between ranibizumab injection and l aser photocoagulation (LP) for type 1 retinopathy of prematurity (ROP), and explore the associated risk factors.
语种	英语
文献类型	期刊论文
条目标识符	http://ir.yic.ac.cn/handle/133337/34557
专题	中国科学院烟台海岸带研究所
作者单位	1.南方医科大学 2.The Seventh Medical Center of Chinese PLA General Hospital 3.中国科学院烟台海岸带研究所 4.the Seventh Medical Center of Chinese PLA General Hospital
推荐引用方式 GB/T 7714	Jing-Ke Cao,Tao Han,Hong-Yi Tang,et al. Comparison of post-treatment recurrence between ranibizumab injection and laser photocoagulation for type 1 retinopathy of prematurity[J]. BMC OPHTHALMOLOGY,2023,23(1):1-8.
APA	Jing-Ke Cao.,Tao Han.,Hong-Yi Tang.,Sheng Zhang.,Zong-Hua Wang.,...&Qiu-Ping Li.(2023).Comparison of post-treatment recurrence between ranibizumab injection and laser photocoagulation for type 1 retinopathy of prematurity.BMC OPHTHALMOLOGY,23(1),1-8.
MLA	Jing-Ke Cao,et al."Comparison of post-treatment recurrence between ranibizumab injection and laser photocoagulation for type 1 retinopathy of prematurity".BMC OPHTHALMOLOGY 23.1(2023):1-8.